Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma.

Autor: Ribeiro, Maurício Fernando Silva Almeida, Gadotti, Luiza Lara, Sacardo, Karina Perez, Lopes, Carlos Diego Holanda, Saddi, Rodrigo, Alessi, João Victor Machado, de Macedo, Mariana Petaccia, do Nascimento, Ellen Caroline Toledo, Testagrossa, Leonardo de Abreu, Katz, Artur
Zdroj: SAGE Open Medical Case Reports; 1/1/2022, Vol. 10, p1-6, 6p
Databáze: Complementary Index